Top of this page
Skip navigation, go straight to the content

Clinical Studies Overview

Welcome to our
Clinical Studies section

 

UCB researchers seek to understand, prevent and treat diseases.
Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs.

 

 



Find out more about a selection of studies

 
Epilepsy in children - "BELLE" study - EP0065

A Multicenter, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects = 1 Month to < 16 Years of Age with Epilepsy.

Recruiting

Status
Epilepsy in children - "ACHIEVE" study - SP0967

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects with Epilepsy >=1 Month to <4 Years of Age with Partial-Onset Seizures.

Recruiting

Status

Nonradiographic axial spondyloarthritis - "BE MOBILE 1" study - AS0010

www.bemobilestudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled StudyA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis.

Recruiting

Status

Ankylosing spondylitis - "BE MOBILE 2" study - AS0011

www.bemobilestudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis.

Recruiting

Status

Psoratic arthritis - "BE OPTIMAL" study - PA0010

www.beoptimalstudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Psoratic arthritis - "BE COMPLETE" study - PA0011

www.becompletestudy.com

A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Drug-resistant Epilepsy - "DUET" study - EP0092

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects With Drug-Resistant Epilepsy

Recruiting

Status

Discover more about our clinical studies

image description
 
 

 

Disease resources

Epilepsy
Rheumatoid arthritis
Osteoporosis
image description
Parkinson's disease
Restless Legs Syndrome
Psoriatic arthritis
Axial Spondyloarthritis
image description
Lupus
Crohn's disease

Want more information on our clinical studies?

Just contact us!

Phone Number: +1-844-599-2273
Email Address: UCBCares@ucb.com